BAFNAPH logo

Bafna Pharmaceuticals Stock Price

Symbol: NSEI:BAFNAPHMarket Cap: ₹2.1bCategory: Pharmaceuticals & Biotech

BAFNAPH Share Price Performance

₹88.72
4.22 (4.99%)
₹88.72
4.22 (4.99%)
Price ₹88.72

BAFNAPH Community Narratives

There are no narratives available yet.

BAFNAPH Community Fair Values

    Recent BAFNAPH News & Updates

    No updates

    Bafna Pharmaceuticals Limited Key Details

    ₹1.5b

    Revenue

    ₹1.0b

    Cost of Revenue

    ₹428.0m

    Gross Profit

    ₹386.4m

    Other Expenses

    ₹41.5m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    1.76
    Gross Margin
    29.34%
    Net Profit Margin
    2.85%
    Debt/Equity Ratio
    33.3%

    Bafna Pharmaceuticals Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About BAFNAPH

    Founded
    1981
    Employees
    363
    CEO
    Bansilal Mahaveer Bafna
    WebsiteView website
    www.bafnapharma.com

    Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

    Indian Market Performance

    • 7 Days: 0.2%
    • 3 Months: 5.2%
    • 1 Year: -2.4%
    • Year to Date: -1.1%
    Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 2.1% in the Financials sector. The market has dropped 6.5% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading